$9.48
At close: Apr 21, 3:37 PM EDT
Comments
Loading...
Sino Biopharmaceutical Analyst Ratings and Price Targets | OTC:SBHMY | Benzinga
Sino Biopharmaceutical Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Sino Biopharmaceutical Corp from these most-recent analyst ratings.
Analyst Ratings for Sino Biopharmaceutical
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Sino Biopharmaceutical (SBHMY) stock?
There is no price target for Sino Biopharmaceutical
What is the most recent analyst rating for Sino Biopharmaceutical (SBHMY)?
There is no analyst for Sino Biopharmaceutical
When was the last upgrade for Sino Biopharmaceutical (SBHMY)?
There is no last upgrade for Sino Biopharmaceutical
When was the last downgrade for Sino Biopharmaceutical (SBHMY)?
There is no last downgrade for Sino Biopharmaceutical.
When is the next analyst rating going to be posted or updated for Sino Biopharmaceutical (SBHMY)?
There is no next analyst rating for Sino Biopharmaceutical.
Is the Analyst Rating Sino Biopharmaceutical (SBHMY) correct?
There is no next analyst rating for Sino Biopharmaceutical.
Browse analyst ratings and price targets on all stocks.
